HUAKANG BIOMED (08622) appoints Qintian Capital as its independent financial advisor.
Huakang Biomedical (08622) announced that Qingtian Capital Limited has obtained a license to engage in securities...
HUAKANG BIOMED (08622) announced that Qingtian Capital Limited has been licensed to engage in regulated activities under Type 6 (providing advice on corporate finance) of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). The company has been appointed as the independent financial advisor to provide advice to the Independent Board Committee, offer shareholders, and offer option holders on the acceptance of the offer and offer. This appointment has been approved by the Independent Board Committee in accordance with Rule 2.1 of the Takeovers Code.
Related Articles
INNOGEN-B(02591): Subscription of structured deposit products worth 105 million RMB
Shandong Kuntai New Material Technology (001260.SZ) reaches cooperation intention with Trves on automobile carpet business.
Zhejiang XiaSha Precision Manufacturing (001306.SZ) intends to establish a 49 million yuan investment fund, with Siasun Robot & Automation as one of the investors in the field.
INNOGEN-B(02591): Subscription of structured deposit products worth 105 million RMB
Shandong Kuntai New Material Technology (001260.SZ) reaches cooperation intention with Trves on automobile carpet business.
Zhejiang XiaSha Precision Manufacturing (001306.SZ) intends to establish a 49 million yuan investment fund, with Siasun Robot & Automation as one of the investors in the field.
RECOMMEND
